INVO Fertility, Inc.

Equities

IVF

US44984F6097

Market Closed - Nasdaq Other stock markets 21:00:00 20/06/2025 BST			5-day change	1st Jan Change
1.220 ^USD	-3.17%		-6.87%	-87.45%

06-18	Invo Fertility, Inc. Expands Telehealth Capabilities At Its Wisconsin Fertility Institute	CI
05-25	INVO Fertility Seeks Acquisitions	CI

INVO Bioscience, Inc., NAYA Biosciences Inc. - Special Call

Published on 31/10/2023 at 15:30

Presenter Speech
John Heerdink (Analysts)

Good morning, everyone. This is John Heerdink. I'm the managing member of Tribe Public. Thank you all for joining, and for all that will join today. Again,

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about INVO Fertility, Inc.

Invo Fertility, Inc. Expands Telehealth Capabilities At Its Wisconsin Fertility Institute	06-18	CI
INVO Fertility Seeks Acquisitions	05-25	CI
INVO Fertility, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	05-20	CI
Top Premarket Gainers	05-05	MT
Invo Fertility Announces 2024 Financial Results	04-30	RE
INVO Fertility, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024	04-30	CI
INVO Fertility, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	04-30	CI
INVO Fertility, Inc. Auditor Raises 'Going Concern' Doubt	04-29	CI
INVO Fertility, Inc. will Change its Ticker to IVF from NAYA	04-28	CI
NAYA Biosciences Renames Itself INVO Fertility; Separates Oncology, Fertility Businesses	04-15	MT
INVO Fertility Plans to Divest A Majority Stake in Naya Therapeutics	04-15	CI
NAYA Biosciences, Inc. has Changed its Name to INVO Fertility, Inc	04-14	CI
Naya Biosciences Inc - Regains Compliance With Nasdaq Listing Rule - SEC Filing	03-31	RE
Naya Biosciences Announces Development of Ny-500, A Novel Ai-Optimized Pd-1 X Vegf Bifunctional Antibody	01-06	CI
NAYA Biosciences, Inc. Announces Executive and Board Appointments	12-12	CI
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma	24/10/24	CI
NAYA Biosciences, Inc.(NasdaqCM:NAYA) added to NASDAQ Composite Index	22/10/24	CI
INVO Bioscience, Inc.(NasdaqCM:INVO) dropped from NASDAQ Composite Index	21/10/24	CI
INVO Bioscience, Inc. Announces Board Changes	15/10/24	CI
INVO BioScience, Inc. has Changed its Name to NAYA Biosciences, Inc	15/10/24	CI
INVO BioScience, Inc. has Changed its Ticker to NAYA from INVO	15/10/24	CI
INVO Bioscience Completes Merger With NAYA Biosciences Acquisition	14/10/24	MT
NAYA Biosciences completed the acquisition of INVO Bioscience, Inc. from Intracoastal Capital LLC and others in a reverse merger transaction.	13/10/24	CI
Earnings Flash (INVO) INVO BIOSCIENCE Posts Q2 Loss $-0.62 Per Share	14/08/24	MT
Earnings Flash (INVO) INVO BIOSCIENCE Posts Q2 Revenue $1.8M	14/08/24	MT